Costs of Interventions to Increase Vaccination Coverage Among Children in the United States: A Systematic Review.

Kai Hong, Andrew J Leidner, Yuping Tsai, Zhaoli Tang, Bo-Hyun Cho, Shannon Stokley
Author Information
  1. Kai Hong: Immunization Service Division, National Center for Immunization and Respiratory Diseases (NCIRD) (K Hong, AJ Leidner, Y Tsai, B-H Cho, and S Stokley), Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Electronic address: khong@cdc.gov.
  2. Andrew J Leidner: Immunization Service Division, National Center for Immunization and Respiratory Diseases (NCIRD) (K Hong, AJ Leidner, Y Tsai, B-H Cho, and S Stokley), Centers for Disease Control and Prevention (CDC), Atlanta, Ga.
  3. Yuping Tsai: Immunization Service Division, National Center for Immunization and Respiratory Diseases (NCIRD) (K Hong, AJ Leidner, Y Tsai, B-H Cho, and S Stokley), Centers for Disease Control and Prevention (CDC), Atlanta, Ga.
  4. Zhaoli Tang: Berry Technology Solutions (Z Tang), Atlanta, Ga.
  5. Bo-Hyun Cho: Immunization Service Division, National Center for Immunization and Respiratory Diseases (NCIRD) (K Hong, AJ Leidner, Y Tsai, B-H Cho, and S Stokley), Centers for Disease Control and Prevention (CDC), Atlanta, Ga.
  6. Shannon Stokley: Immunization Service Division, National Center for Immunization and Respiratory Diseases (NCIRD) (K Hong, AJ Leidner, Y Tsai, B-H Cho, and S Stokley), Centers for Disease Control and Prevention (CDC), Atlanta, Ga.

Abstract

BACKGROUND: The Community Preventive Services Task Force (CPSTF) has recommended several interventions that have been demonstrated to be effective at increasing vaccination coverage.
OBJECTIVE: Conduct a systematic review to examine the costs of interventions designed to increase vaccination coverage among children and adolescents in the United States.
DATA SOURCES: PubMed, EconLit, Embase, and Cochrane.
STUDY ELIGIBILITY, PARTICIPANTS, AND INTERVENTIONS: Peer-reviewed articles from January 1, 2009 to August 31, 2019.
APPRAISAL AND SYNTHESIS METHODS: Studies were identified with systematic searches of the literature, reviewed for inclusion criteria, abstracted for data on intervention, target population, costs, and risk of bias. Cost measures were reported as costs per child in the target population, costs per vaccinated child, incremental costs per vaccinated child, and costs per vaccine dose administered. Results were stratified by intervention type, vaccine, and age group.
RESULTS: Thirty-seven studies were identified for full-text review. Across all interventions and age groups, the cost per child ranged from $0.10 to $537.38, and the incremental cost per vaccinated child ranged from $6.52 to $5,098.57. Provider assessment and feedback interventions had the lowest (median) cost per child ($0.17) and a healthcare system-based combined intervention with multiple components had the lowest (median) incremental cost per vaccinated child ($26.65). A community-based combined intervention with multiple components had the highest median cost per child ($537.38) and the highest median incremental cost per vaccinated child ($5,098.57).
LIMITATIONS: A small number of included intervention types and inconsistent cost definition.
CONCLUSIONS: There is substantial variability in the costs of CPSTF-recommended interventions.

Keywords

References

  1. Acad Pediatr. 2017 Apr;17(3):330-338 [PMID: 27913163]
  2. JAMA Pediatr. 2015 Apr;169(4):365-73 [PMID: 25706340]
  3. Hum Vaccin. 2009 Jun;5(6):395-402 [PMID: 19029825]
  4. J Adolesc Health. 2016 Oct;59(4S):S40-S48 [PMID: 27664595]
  5. Am J Prev Med. 2016 Jun;50(6):797-808 [PMID: 26847663]
  6. Pediatrics. 2009 Aug;124(2):455-64 [PMID: 19651574]
  7. Pediatrics. 2012 Jun;129(6):e1437-45 [PMID: 22566415]
  8. J Public Health Manag Pract. 2015 May-Jun;21(3):253-62 [PMID: 24912081]
  9. BMC Health Serv Res. 2015 Nov 16;15:511 [PMID: 26573461]
  10. Hum Vaccin Immunother. 2016 Jun 2;12(6):1566-88 [PMID: 26838959]
  11. Health Serv Res. 2017 Dec;52 Suppl 2:2307-2330 [PMID: 29130266]
  12. Prev Med. 2017 Jun;99:277-281 [PMID: 28322881]
  13. J Public Health Manag Pract. 2018 Nov/Dec;24(6):558-566 [PMID: 30277479]
  14. J Sch Nurs. 2012 Oct;28(5):328-35 [PMID: 22691394]
  15. Clin Med Res. 2015 Jun;13(2):51-7 [PMID: 25380614]
  16. Pediatrics. 2014 Aug;134(2):e346-53 [PMID: 25002671]
  17. Pediatrics. 2014 Apr;133(4):577-85 [PMID: 24590750]
  18. Pediatrics. 2015 Nov;136(5):e1220-7 [PMID: 26438703]
  19. Am J Manag Care. 2010 Mar;16(3):217-24 [PMID: 20225917]
  20. Vaccine. 2018 Jun 14;36(25):3641-3649 [PMID: 29754699]
  21. J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):e74-9 [PMID: 23023861]
  22. Pediatrics. 2012 Jun;129(6):e1446-52 [PMID: 22566414]
  23. Am J Public Health. 2012 Jul;102(7):1378-83 [PMID: 22676501]
  24. Pediatrics. 2013 Jun;131(6):1114-24 [PMID: 23650297]
  25. Biosecur Bioterror. 2010 Dec;8(4):331-41 [PMID: 21054182]
  26. Emerg Infect Dis. 2010 Feb;16(2):244-50 [PMID: 20113554]
  27. Am J Public Health. 2013 Jun;103(6):1116-23 [PMID: 23237154]
  28. Vaccine. 2016 May 23;34(24):2737-44 [PMID: 27126875]
  29. Am J Prev Med. 2000 Jan;18(1 Suppl):97-140 [PMID: 10806982]
  30. Acad Pediatr. 2017 Apr;17(3):323-329 [PMID: 26968339]
  31. J Adolesc Health. 2015 May;56(5 Suppl):S27-32 [PMID: 25863551]
  32. Arch Pediatr Adolesc Med. 2011 Jun;165(6):547-53 [PMID: 21646588]
  33. Health Educ Behav. 2014 Dec;41(6):625-32 [PMID: 24786792]
  34. Am J Health Behav. 2014 Jan;38(1):92-102 [PMID: 24034684]
  35. Implement Sci. 2014 Feb 18;9:21 [PMID: 24533515]
  36. J Adolesc Health. 2014 Mar;54(3):282-8 [PMID: 24560036]
  37. Vaccine. 2018 Aug 6;36(32 Pt B):4904-4909 [PMID: 30037480]
  38. MMWR Morb Mortal Wkly Rep. 2014 Apr 25;63(16):352-5 [PMID: 24759657]
  39. Acad Pediatr. 2012 Mar-Apr;12(2):104-9 [PMID: 22321815]
  40. JAMA. 2012 Apr 25;307(16):1702-8 [PMID: 22535855]
  41. J Sch Nurs. 2012 Oct;28(5):336-43 [PMID: 22914801]
  42. Am J Prev Med. 2018 Feb;54(2):299-315 [PMID: 29362167]
  43. Acad Pediatr. 2014 May-Jun;14(3):234-40 [PMID: 24767776]
  44. Vaccine. 2013 Apr 19;31(17):2156-64 [PMID: 23499607]
  45. BMC Health Serv Res. 2019 Jun 24;19(1):407 [PMID: 31234842]
  46. Acad Pediatr. 2013 May-Jun;13(3):204-13 [PMID: 23510607]
  47. BMJ. 2011 Oct 18;343:d5928 [PMID: 22008217]
  48. Am J Prev Med. 2000 Jan;18(1 Suppl):35-43 [PMID: 10806978]
  49. Pediatrics. 2016 Mar;137(3):e20150675 [PMID: 26908681]
  50. J Adolesc Health. 2015 May;56(5 Suppl):S21-6 [PMID: 25863550]
  51. J Clin Epidemiol. 2020 May;121:20-28 [PMID: 31972274]

Grants

  1. CC999999/Intramural CDC HHS
  2. /CDC HHS

MeSH Term

Adolescent
Child
Cost-Benefit Analysis
Family
Humans
United States
Vaccination
Vaccination Coverage

Word Cloud

Created with Highcharts 10.0.0perchildcostscostinterventionsinterventionvaccinatedincrementalmedianvaccinationcoveragesystematicreviewUnitedStatesANDidentifiedtargetpopulationvaccineageranged$0$53738$509857lowestcombinedmultiplecomponentshighestinfantBACKGROUND:CommunityPreventiveServicesTaskForceCPSTFrecommendedseveraldemonstratedeffectiveincreasingOBJECTIVE:ConductexaminedesignedincreaseamongchildrenadolescentsDATASOURCES:PubMedEconLitEmbaseCochraneSTUDYELIGIBILITYPARTICIPANTSINTERVENTIONS:Peer-reviewedarticlesJanuary12009August312019APPRAISALSYNTHESISMETHODS:StudiessearchesliteraturereviewedinclusioncriteriaabstracteddatariskbiasCostmeasuresreporteddoseadministeredResultsstratifiedtypegroupRESULTS:Thirty-sevenstudiesfull-textAcrossgroups10$652Providerassessmentfeedback17healthcaresystem-based$2665community-basedLIMITATIONS:smallnumberincludedtypesinconsistentdefinitionCONCLUSIONS:substantialvariabilityCPSTF-recommendedCostsInterventionsIncreaseVaccinationCoverageAmongChildrenStates:SystematicReviewChildpreschooladolescentanalysisnewborn

Similar Articles

Cited By (3)